The novel curcumin derivative 1g induces mitochondrial and
ER-stress-dependent apoptosis in colon cancer cells by induction of ROS
production
Abstract
Background and Purpose A novel curcumin (Cur) derivative 1g can inhibit
the proliferation of colon cancer in vitro and in vivo. The purpose of
this study was to explore the role of 1g in inducing apoptosis of colon
cancer cells, especially mitochondrial apoptosis and endoplasmic
reticulum (ER)-stress caused by reactive oxygen species (ROS).
Experimental Approach Bioinformatics was used to analyze differentially
expressed mrnas. Gene expression was measured by using qRT-PCR and
protein expression was measured by using western blotting. Cell
apoptosis, cycle, mitochondrial membrane potential and ROS were analyzed
by flow cytometry. Experiments on transplanted tumors in animals. Key
Results The mechanism of this effect was a change in mitochondrial
membrane potential caused by 1g that increased its pro-apoptotic
activity. In addition, 1g produced ROS, induced G1 checkpoint blockade,
and enhanced ER-stress in colon cancer cells. On the contrary,
pretreatment with the ROS scavenging agent N-acetyl-l-cysteine (NAC)
inhibited the mitochondrial dysfunction caused by 1g and reversed
ER-stress, cell cycle stagnation, and apoptosis. Additionally,
pretreatment with the p-PERK inhibitor GSK2606414 significantly reduced
ER-stress and reversed the apoptosis induced by colon cancer cells.
Conclusion and Implications This study not only found that 1g inherits
the safety of Cur and has a more inhibitory effect on colon cancer cells
than Cur, but also revealed that excessive production of ROS is one of
the mechanisms of anti-tumor action.